Cystic Fibrosis (CF) Therapeutics Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cystic Fibrosis (CF) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cystic Fibrosis (CF) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cystic Fibrosis (CF) Therapeutics Overall Market Size
2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size: 2021 VS 2027
2.2 Global Cystic Fibrosis (CF) Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cystic Fibrosis (CF) Therapeutics Players in Global Market
3.2 Top Global Cystic Fibrosis (CF) Therapeutics Companies Ranked by Revenue
3.3 Global Cystic Fibrosis (CF) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cystic Fibrosis (CF) Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cystic Fibrosis (CF) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis (CF) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Cystic Fibrosis (CF) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis (CF) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cystic Fibrosis (CF) Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Pancreatic enzyme supplements
4.1.3 Mucolytics
4.1.4 Bronchodilators
4.1.5 CFTR modulators
4.2 By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cystic Fibrosis (CF) Therapeutics Market Size, 2021 & 2027
5.1.2 Oral drugs
5.1.3 Inhaled drugs
5.2 By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Cystic Fibrosis (CF) Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027
6.3.2 US Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.3.3 Canada Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.3.4 Mexico Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027
6.4.2 Germany Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.3 France Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.4 U.K. Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.5 Italy Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.6 Russia Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.4.8 Benelux Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027
6.5.2 China Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.5.3 Japan Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.5.4 South Korea Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.5.6 India Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027
6.6.2 Brazil Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.6.3 Argentina Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027
6.7.2 Turkey Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.7.3 Israel Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
6.7.5 UAE Cystic Fibrosis (CF) Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Vertex Pharmaceuticalsorporated
7.1.1 Vertex Pharmaceuticalsorporated Corporate Summary
7.1.2 Vertex Pharmaceuticalsorporated Business Overview
7.1.3 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.1.4 Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.1.5 Vertex Pharmaceuticalsorporated Key News
7.2 Gilead
7.2.1 Gilead Corporate Summary
7.2.2 Gilead Business Overview
7.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.2.4 Gilead Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.2.5 Gilead Key News
7.3 AbbVie,
7.3.1 AbbVie, Corporate Summary
7.3.2 AbbVie, Business Overview
7.3.3 AbbVie, Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.3.4 AbbVie, Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.3.5 AbbVie, Key News
7.4 Novartis AG
7.4.1 Novartis AG Corporate Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.4.4 Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.4.5 Novartis AG Key News
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.5.5 F. Hoffmann-La Roche Ltd Key News
7.6 Alaxia
7.6.1 Alaxia Corporate Summary
7.6.2 Alaxia Business Overview
7.6.3 Alaxia Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.6.4 Alaxia Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.6.5 Alaxia Key News
7.7 Merck & Co.
7.7.1 Merck & Co. Corporate Summary
7.7.2 Merck & Co. Business Overview
7.7.3 Merck & Co. Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.4.4 Merck & Co. Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.7.5 Merck & Co. Key News
7.8 AIT (Advanced Inhalation Therapies)
7.8.1 AIT (Advanced Inhalation Therapies) Corporate Summary
7.8.2 AIT (Advanced Inhalation Therapies) Business Overview
7.8.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.8.4 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.8.5 AIT (Advanced Inhalation Therapies) Key News
7.9 ALLERGAN
7.9.1 ALLERGAN Corporate Summary
7.9.2 ALLERGAN Business Overview
7.9.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.9.4 ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.9.5 ALLERGAN Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.10.4 AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.10.5 AstraZeneca Key News
7.11 Teva Pharmaceutical Industries Ltd
7.11.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.11.2 Teva Pharmaceutical Industries Ltd Business Overview
7.11.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.11.4 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.11.5 Teva Pharmaceutical Industries Ltd Key News
7.12 Alcresta
7.12.1 Alcresta Corporate Summary
7.12.2 Alcresta Business Overview
7.12.3 Alcresta Cystic Fibrosis (CF) Therapeutics Major Product Offerings
7.12.4 Alcresta Cystic Fibrosis (CF) Therapeutics Revenue in Global (2016-2021)
7.12.5 Alcresta Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Cystic Fibrosis (CF) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Cystic Fibrosis (CF) Therapeutics Market Drivers in Global Market
Table 3. Cystic Fibrosis (CF) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Cystic Fibrosis (CF) Therapeutics in Global Market
Table 5. Top Cystic Fibrosis (CF) Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cystic Fibrosis (CF) Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cystic Fibrosis (CF) Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cystic Fibrosis (CF) Therapeutics Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis (CF) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis (CF) Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cystic Fibrosis (CF) Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cystic Fibrosis (CF) Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cystic Fibrosis (CF) Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cystic Fibrosis (CF) Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Vertex Pharmaceuticalsorporated Corporate Summary
Table 31. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 32. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Gilead Corporate Summary
Table 34. Gilead Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 35. Gilead Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. AbbVie, Corporate Summary
Table 37. AbbVie, Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 38. AbbVie, Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 41. Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. F. Hoffmann-La Roche Ltd Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 44. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Alaxia Corporate Summary
Table 46. Alaxia Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 47. Alaxia Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. Merck & Co. Corporate Summary
Table 49. Merck & Co. Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 50. Merck & Co. Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. AIT (Advanced Inhalation Therapies) Corporate Summary
Table 52. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 53. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. ALLERGAN Corporate Summary
Table 55. ALLERGAN Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 56. ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. AstraZeneca Corporate Summary
Table 58. AstraZeneca Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 59. AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 61. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 62. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Alcresta Corporate Summary
Table 64. Alcresta Cystic Fibrosis (CF) Therapeutics Product Offerings
Table 65. Alcresta Cystic Fibrosis (CF) Therapeutics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Cystic Fibrosis (CF) Therapeutics Segment by Type
Figure 2. Cystic Fibrosis (CF) Therapeutics Segment by Application
Figure 3. Global Cystic Fibrosis (CF) Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cystic Fibrosis (CF) Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cystic Fibrosis (CF) Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2020
Figure 8. By Type - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cystic Fibrosis (CF) Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cystic Fibrosis (CF) Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Gilead Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. AbbVie, Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Novartis AG Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Alaxia Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Merck & Co. Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. ALLERGAN Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. AstraZeneca Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Alcresta Cystic Fibrosis (CF) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta